Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for risk stratification remain elusive. This study sought to explore the ...

Six years after undergoing either surgery or TAVR with a CoreValve, Evolut R or Evolut PRO, low-risk patients with aortic stenosis (AS) experienced no significant differences in terms of all-cause ...